The iron-sulfur cluster assembly factor FDX2 is required for tumor initiation but not for growth of established tumors in transplantation models
Open Access
- 27 May 2026
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (7) , 113200
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (23K08577)
- Japan Society for the Promotion of Science (26K12008)
- Japan Society for the Promotion of Science (24K12614)
- Japan Society for the Promotion of Science (24K23502)
- Japan Society for the Promotion of Science (23H02757)
- Japan Society for the Promotion of Science (25K20075)
- Japan Society for the Promotion of Science (26K02285)
- Naito Foundation
This publication has 41 references indexed in Scilit:
- FDX2, an iron-sulfur cluster assembly factor, is essential to prevent cellular senescence, apoptosis or ferroptosis of ovarian cancer cellsJournal of Biological Chemistry, 2024
- Lipoylation is dependent on the ferredoxin FDX1 and dispensable under hypoxia in human cellsJournal of Biological Chemistry, 2023
- IL-1β-associated NNT acetylation orchestrates iron-sulfur cluster maintenance and cancer immunotherapy resistanceMolecular Cell, 2023
- A web-based integrative transcriptome analysis, RNAseqChef, uncovers the cell/tissue type-dependent action of sulforaphaneJournal of Biological Chemistry, 2023
- Oxygen toxicity causes cyclic damage by destabilizing specific Fe-S cluster-containing protein complexesMolecular Cell, 2023
- Divergent metabolic responses dictate vulnerability to NAMPT inhibition in ovarian cancerFEBS Letters, 2020
- Cellular Senescence: Defining a Path ForwardCell, 2019
- Hypoxia Rescues Frataxin Loss by Restoring Iron Sulfur Cluster BiogenesisCell, 2019
- PKM1 Confers Metabolic Advantages and Promotes Cell-Autonomous Tumor Cell GrowthCancer Cell, 2018
- Fe–S proteins that regulate gene expressionBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2015